2013 American Transplant Congress
Targeting Inositol-Requiring Enzyme 1α in Prevention of Donor Specific Antibody (DSA) Mediated Rejection
Introduction: Inositol-requiring enzyme 1Α (IRE1Α), an endoplasmic reticulum-located transmembrane protein kinase, is the activator of transcription factor X-box-binding protein 1 (XBP1) that is required for…2013 American Transplant Congress
Simultaneous Pancreas-Kidney Transplantation in Patients with End-Stage Nephropathy Due to Type 2 Diabetes Mellitus Gives Better Results When Compared to Kidney Transplants Alone
Objective: SPK in type 2 diabetes (T2DM) is performed by a few centers in selected patients. The purpose of the study was to compare patient…2013 American Transplant Congress
Modified Technique of Auxiliary Partial Liver Transplantation in Rat for the Study of Liver Regeneration and Tissue Engineering In Vivo, A
Background:Organ engineering and regenerative medicine using decellularized liver scaffolds offer a promising solution to organ shortage. Auxiliary partial liver transplantation (APLT) in rat is considered…2013 American Transplant Congress
Different Effects of mTOR Inhibitor VS CN Inhibitor on Human B Cells Proliferations and Activation Markers
Background: Humoral immunity is increasingly recognized as an important factor in promoting transplant rejection. However, it is not well known how commonly used immunosuppressive drugs…2013 American Transplant Congress
CD39 Regulates the Activation of Liver DC and Protects Against Liver Transplant Ischemic Reperfusion Injury
Background: ATP is an energy source stored in the cell cytosol. Once released into extracellular(e) space as a result of cell injury/death, eATP acts in…2013 American Transplant Congress
Effects of Viral Infection on Chronic Anti-Mediated Rejection, The
Emory Transplant Center, Atlanta
[Background] Despite a 50% decline in acute rejection over the past 10 years, antibody-mediated injury has been identified as perhaps the leading cause of chronic…2013 American Transplant Congress
Does Secondary Prophylaxis Prevent CMV Relapse Following Treatment of CMV Disease in Kidney Transplant Recipients?
Division of Infectious Diseases, Mount Sinai Hospital, New York, NY
BackgroundAlthough many centers use secondary prophylaxis to prevent relapse following the treatment of CMV disease in kidney transplant recipients (KTR), there is limited data to…2013 American Transplant Congress
Novel Model of Antibody Mediated Rejection of Kidney Allografts in Rats, A
We have developed a new experimental model of acute ABMR, in which complete MHC mismatched kidneys are transplanted from Brown Norway rats (RT1n) into Lewis…2013 American Transplant Congress
Donor Comorbidities Rather Than Age Alone Determine Recipient Outcomes in "SCD" Kidney Transplants
The Transplant Institute, Henry Ford Hospital, Detroit, MI
Deceased donor (DD) pool has been expanded with kidneys that have wide-ranging functional vitality and pathologic features stemming from increasing incidence of metabolic syndrome. To…2013 American Transplant Congress
Non-Renal Solid Organ Transplant (NRSOT): The Role of the Transplant Nephrologist before Advanced Stage Chronic Kidney Disease (CKD)
Background: Many patients who have not undergone appropriate kidney evaluation pre-NRSOT are found to have progressive or end-stage renal disease post-NRSOT. Recipients of NRSOT who…
- « Previous Page
- 1
- …
- 96
- 97
- 98
- 99
- 100
- …
- 178
- Next Page »